Sterling Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$52.4K	Buy	461 +152	+49%	+$17.3K	﹤0.01%	1491
2025 Q1	$32.5K	Sell	309 -237	-43%	-$24.9K	﹤0.01%	1531
2024 Q4	$58.5K	Buy	546 +487	+825%	+$52.2K	﹤0.01%	1572
2024 Q3	$5.91K	Buy	+59	New	+$5.91K	﹤0.01%	1698